Thornton and Ross Ltd: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyHuddersfieldNationwide (UK)Main market: Pharmaceutical products

Official UK PPONPWYH-6892-QYNNCompanies House00185947 ↗ · Active

Where they win
i

132 awards (128 for a named lot, 97%, 4 for a whole procedure with no lot named) · top CPV classes, shares of all 132 awards. An award may cover more than one class.

3360 Pharmaceutical products130 awards · 98% · 126 awards naming a lot + 4 whole-procedure awards
3369 Various medicinal products2 awards · 2% · awards naming a lot
Attributable award value
i
£7.3mOn 11 of 132 award records; the five largest make 84%. Largest rows below.
Typical attributable award
i
£335k middle valuerobust · n=11

Where their buyers are
i

ITL1 region of the buyer office · known for 87 of 87 awarded procedures · each procedure counts once

Greater London41 procedures · 47%
Scotland20 procedures · 23%
Wales (Cymru)15 procedures · 17%
North West England10 procedures · 11%
Northern Ireland1 procedure · 1%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 13 notices name this supplier, covering 16 lots since 20 Aug 2025 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
12 of 16Lots on 13 notices: a place is won per lot.
Authorities bid for
i
1

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health96%(127 awards)
    127 of 132 awards are NHS & health (96%).
  • Type not classified4%(5 awards)
    5 of 132 awards are Type not classified (4%).
AuthorityProceduresShareAward recordsLast activity
NHS Englandframework/DPS on 404046%6427 Aug 2026
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")framework/DPS on 202023%331 Jul 2025
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)framework/DPS on 11314.9%1317 Sept 2026
The NHS Commissioning Board (operating under the name of NHS England)framework/DPS on 101011.5%187 Feb 2022
eTenderwales22.3%217 Jun 2025
Business Services Organisation Procurement and Logistics Serviceframework/DPS on 111.1%35 Jan 2026
NHS Supply Chainframework/DPS on 111.1%120 Aug 2021

Share = of the 87 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

103 of 134 awards carry an end date, 30 estimated from the duration · not a retender forecast

Soonest 10 of 17.

Recent awards

Latest 30 of 132 award records naming this supplier

Contracts Finder adds 2 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

Award / procedureAuthorityAwardedPublished value
Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only productsNHS England13 Jan 2026£403,702,000
framework ceiling · 1 of 104 appointed suppliers
Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and DapagliflozinNHS England25 Nov 2025£25,881,000
framework ceiling · 1 of 8 appointed suppliers
NHS National Framework for Generics Housekeeping Lot 1 - Oral ProductsNHS England10 Nov 2025£17,843,324
framework ceiling · 1 of 21 appointed suppliers
Lot 1 - CM/PHS/25/5728/01NHS England31 Jul 2025£688,834,174
framework ceiling · 1 of 10 appointed suppliers
Lot 2 - CM/PHS/25/5728/02NHS England31 Jul 2025£782,917,972
framework ceiling · 1 of 14 appointed suppliers
NHS National Framework for Transition products (Axitinib and Eltrombopag)NHS England16 Jul 2025£52,385,000
framework ceiling · 1 of 7 appointed suppliers
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026NHS EnglandNot published£665,389,588 †
framework ceiling · 1 of 24 appointed suppliers
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026NHS EnglandNot published£813,863,584 †
framework ceiling · 1 of 25 appointed suppliers
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026NHS EnglandNot published£18,903,212 †
framework ceiling · 1 of 8 appointed suppliers
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Business Services Organisation Procurement and Logistics ServiceNot published£37,124 †
dynamic market estimate · not attributable revenue
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 73 of 134 awards, estimated from the published duration on 30 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.